Literature DB >> 15795274

Retroviral recombination in vivo: viral replication patterns and genetic structure of simian immunodeficiency virus (SIV) populations in rhesus macaques after simultaneous or sequential intravaginal inoculation with SIVmac239Deltavpx/Deltavpr and SIVmac239Deltanef.

Eun-Young Kim1, Marc Busch, Kristina Abel, Linda Fritts, Patty Bustamante, Jenny Stanton, Ding Lu, Samuel Wu, Jenny Glowczwskie, Tracy Rourke, Derek Bogdan, Mike Piatak, Jeffrey D Lifson, Ronald C Desrosiers, Steven Wolinsky, Christopher J Miller.   

Abstract

To characterize the occurrence, frequency, and kinetics of retroviral recombination in vivo, we intravaginally inoculated rhesus macaques, either simultaneously or sequentially, with attenuated simian immunodeficiency virus (SIV) strains having complementary deletions in their accessory genes and various degrees of replication impairment. In monkeys inoculated simultaneously with SIVmac239Deltavpx/Deltavpr and SIVmac239Deltanef, recombinant wild-type (wt) virus and wild-type levels of plasma viral RNA (vRNA) were detected in blood by 2 weeks postinoculation. In monkeys inoculated first with SIVmac239Deltavpx/Deltavpr and then with SIVmac239Deltanef, recombination occurred but was associated with lower plasma vRNA levels than plasma vRNA levels seen for monkeys inoculated intravaginally with wt SIVmac239. In one monkey, recombination occurred 6 weeks after the challenge with SIVmac239Deltanef when plasma SIVmac239Deltavpx/Deltavpr RNA levels were undetectable. In monkeys inoculated first with the more highly replicating strain, SIVmac239Deltanef, and then with SIVmac239Deltavpx/Deltavpr, wild-type recombinant virus was not detected in blood or tissues. Instead, a virus that had repaired the deletion in the nef gene by a compensatory mutation was found in one animal. Overall, recombinant SIV was eventually found in four of six animals intravaginally inoculated with the two SIVmac239 deletion mutants. These findings show that recombination can occur readily in vivo after mucosal SIV exposure and thus contributes to the generation of viral genetic diversity and enhancement of viral fitness.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15795274      PMCID: PMC1069535          DOI: 10.1128/JVI.79.8.4886-4895.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

Review 1.  HIV-1 sequence variation: drift, shift, and attenuation.

Authors:  M H Malim; M Emerman
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

Review 2.  Genetic diversity of HIV-1: the moving target.

Authors:  M Peeters; P M Sharp
Journal:  AIDS       Date:  2000       Impact factor: 4.177

Review 3.  Understanding the genetic diversity of HIV-1.

Authors:  F E McCutchan
Journal:  AIDS       Date:  2000       Impact factor: 4.177

4.  Targeted lymph-node immunization with whole inactivated simian immunodeficiency virus (SIV) or envelope and core subunit antigen vaccines does not reliably protect rhesus macaques from vaginal challenge with SIVmac251.

Authors:  X Lü; H Kiyono; D Lu; S Kawabata; J Torten; S Srinivasan; P J Dailey; J R McGhee; T Lehner; C J Miller
Journal:  AIDS       Date:  1998-01-01       Impact factor: 4.177

5.  Gender differences in HIV-1 diversity at time of infection.

Authors:  E M Long; H L Martin; J K Kreiss; S M Rainwater; L Lavreys; D J Jackson; J Rakwar; K Mandaliya; J Overbaugh
Journal:  Nat Med       Date:  2000-01       Impact factor: 53.440

6.  Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya.

Authors:  J R Neilson; G C John; J K Carr; P Lewis; J K Kreiss; S Jackson; R W Nduati; D Mbori-Ngacha; D D Panteleeff; S Bodrug; C Giachetti; M A Bott; B A Richardson; J Bwayo; J Ndinya-Achola; J Overbaugh
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

7.  Human immunodeficiency virus type 1 intergroup (M/O) recombination in cameroon.

Authors:  J Takehisa; L Zekeng; E Ido; Y Yamaguchi-Kabata; I Mboudjeka; Y Harada; T Miura; L Kaptu; M Hayami
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

8.  Titration of an SIVmac251 stock by vaginal inoculation of Indian and Chinese origin rhesus macaques: transmission efficiency, viral loads, and antibody responses.

Authors:  M L Marthas; D Lu; M C Penedo; A G Hendrickx; C J Miller
Journal:  AIDS Res Hum Retroviruses       Date:  2001-10-10       Impact factor: 2.205

9.  Role of CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment.

Authors:  J D Lifson; J L Rossio; M Piatak; T Parks; L Li; R Kiser; V Coalter; B Fisher; B M Flynn; S Czajak; V M Hirsch; K A Reimann; J E Schmitz; J Ghrayeb; N Bischofberger; M A Nowak; R C Desrosiers; D Wodarz
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

10.  Temporal analyses of virus replication, immune responses, and efficacy in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine.

Authors:  R I Connor; D C Montefiori; J M Binley; J P Moore; S Bonhoeffer; A Gettie; E A Fenamore; K E Sheridan; D D Ho; P J Dailey; P A Marx
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

View more
  18 in total

1.  High frequency of genetic recombination is a common feature of primate lentivirus replication.

Authors:  Jianbo Chen; Douglas Powell; Wei-Shau Hu
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

2.  Latent HIV-1 can be reactivated by cellular superinfection in a Tat-dependent manner, which can lead to the emergence of multidrug-resistant recombinant viruses.

Authors:  Daniel A Donahue; Sophie M Bastarache; Richard D Sloan; Mark A Wainberg
Journal:  J Virol       Date:  2013-06-26       Impact factor: 5.103

3.  Comparison of the replication and persistence of simian-human immunodeficiency viruses expressing Vif proteins with mutation of the SLQYLA or HCCH domains in macaques.

Authors:  Kimberly Schmitt; M Sarah Hill; Zhenqian Liu; Autumn Ruiz; Nathan Culley; David M Pinson; Edward B Stephens
Journal:  Virology       Date:  2010-09-01       Impact factor: 3.616

4.  HIV-1 pathogenesis: the virus.

Authors:  Ronald Swanstrom; John Coffin
Journal:  Cold Spring Harb Perspect Med       Date:  2012-12-01       Impact factor: 6.915

5.  The Toll-like receptor 7 (TLR7) agonist, imiquimod, and the TLR9 agonist, CpG ODN, induce antiviral cytokines and chemokines but do not prevent vaginal transmission of simian immunodeficiency virus when applied intravaginally to rhesus macaques.

Authors:  Yichuan Wang; Kristina Abel; Katherine Lantz; Arthur M Krieg; Michael B McChesney; Christopher J Miller
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

Review 6.  Is an HIV vaccine possible?

Authors:  Nancy A Wilson; David I Watkins
Journal:  Braz J Infect Dis       Date:  2009-08       Impact factor: 1.949

7.  Relative replication capacity of phenotypic SIV variants during primary infections differs with route of inoculation.

Authors:  Tasha Biesinger; Robert White; Monica T Yu Kimata; Brenda K Wilson; Jonathan S Allan; Jason T Kimata
Journal:  Retrovirology       Date:  2010-10-13       Impact factor: 4.602

8.  Protection of macaques with diverse MHC genotypes against a heterologous SIV by vaccination with a deglycosylated live-attenuated SIV.

Authors:  Chie Sugimoto; Satoru Watanabe; Taeko Naruse; Eiji Kajiwara; Teiichiro Shiino; Natsuko Umano; Kayoko Ueda; Hirotaka Sato; Shinji Ohgimoto; Vanessa Hirsch; Francois Villinger; Aftab A Ansari; Akinori Kimura; Masaaki Miyazawa; Yasuo Suzuki; Naoki Yamamoto; Yoshiyuki Nagai; Kazuyasu Mori
Journal:  PLoS One       Date:  2010-07-20       Impact factor: 3.240

9.  SHIV infection protects against heterologous pathogenic SHIV challenge in macaques: a gold-standard for HIV-1 vaccine development?

Authors:  Robert Sealy; Xiaoyan Zhan; Timothy D Lockey; Louis Martin; James Blanchard; Vicki Traina-Dorge; Julia L Hurwitz
Journal:  Curr HIV Res       Date:  2009-09       Impact factor: 1.581

10.  Efficient entry inhibition of human and nonhuman primate immunodeficiency virus by cell surface-expressed gp41-derived peptides.

Authors:  R C Zahn; F G Hermann; E-Y Kim; M D Rett; S M Wolinsky; R P Johnson; F Villinger; D von Laer; J E Schmitz
Journal:  Gene Ther       Date:  2008-05-01       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.